Active	Status	Sponsor type	Region	Phase	Filter
4 Active 8 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Messina, John
OPN-FLU-CS-3206, NCT03960580 / 2019-000648-86: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps	Completed	3	223	Europe, US, RoW	OPN-375	Optinose US Inc.	Chronic Rhinosinusitis	05/22	05/22
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps	Recruiting	3	120	US	OPN-375	Optinose US Inc.	Bilateral Nasal Polyposis	03/26	03/26
Carothers, Jennifer
OPN-FLU-CS-3206, NCT03960580 / 2019-000648-86: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps	Completed	3	223	Europe, US, RoW	OPN-375	Optinose US Inc.	Chronic Rhinosinusitis	05/22	05/22
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps	Recruiting	3	120	US	OPN-375	Optinose US Inc.	Bilateral Nasal Polyposis	03/26	03/26
Vasquez, Jocelyn Nairovi Villasenor
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Messina, John
OPN-FLU-CS-3206, NCT03960580 / 2019-000648-86: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps	Completed	3	223	Europe, US, RoW	OPN-375	Optinose US Inc.	Chronic Rhinosinusitis	05/22	05/22
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps	Recruiting	3	120	US	OPN-375	Optinose US Inc.	Bilateral Nasal Polyposis	03/26	03/26
Carothers, Jennifer
OPN-FLU-CS-3206, NCT03960580 / 2019-000648-86: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps	Completed	3	223	Europe, US, RoW	OPN-375	Optinose US Inc.	Chronic Rhinosinusitis	05/22	05/22
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps	Recruiting	3	120	US	OPN-375	Optinose US Inc.	Bilateral Nasal Polyposis	03/26	03/26
Vasquez, Jocelyn Nairovi Villasenor
No trials found